P. Du-buf-vereijken, A. Branten, and J. Wetzels, Idiopathic Membranous Nephropathy: Outline and Rationale of a Treatment Strategy, American Journal of Kidney Diseases, vol.46, issue.6, pp.1012-1029, 2005.
DOI : 10.1053/j.ajkd.2005.08.020

R. Glassock, Secondary membranous glomerulonephritis, Nephrol Dial Transplant, vol.7, pp.64-71, 1992.

L. Beck, . Jr, R. Bonegio, G. Lambeau, D. Beck et al., Receptor as Target Antigen in Idiopathic Membranous Nephropathy, New England Journal of Medicine, vol.361, issue.1, pp.11-21, 2009.
DOI : 10.1056/NEJMoa0810457
URL : https://hal.archives-ouvertes.fr/hal-00417718

H. Stanescu, M. Arcos-burgos, A. Medlar, D. Bockenhauer, A. Kottgen et al., R1 Alleles in Idiopathic Membranous Nephropathy, Risk HLA-DQA1 and PLA(2)R1 alleles in idiopathic membranous nephropathy, pp.616-626, 2011.
DOI : 10.1056/NEJMoa1009742

J. Hofstra, L. Beck, . Jr, D. Beck, J. Wetzels et al., Anti-Phospholipase A2 Receptor Antibodies Correlate with Clinical Status in Idiopathic Membranous Nephropathy, Clinical Journal of the American Society of Nephrology, vol.6, issue.6, pp.1286-1291, 2011.
DOI : 10.2215/CJN.07210810

W. Qin, L. Beck, . Jr, C. Zeng, Z. Chen et al., Anti-Phospholipase A2 Receptor Antibody in Membranous Nephropathy, Journal of the American Society of Nephrology, vol.22, issue.6, pp.1137-1143, 2011.
DOI : 10.1681/ASN.2010090967

L. Beck, . Jr, F. Fervenza, D. Beck, R. Bonegio et al., Rituximab-Induced Depletion of Anti-PLA2R Autoantibodies Predicts Response in Membranous Nephropathy, Journal of the American Society of Nephrology, vol.22, issue.8, pp.1543-1550, 2011.
DOI : 10.1681/ASN.2010111125

E. Hoxha, S. Harendza, G. Zahner, U. Panzer, O. Steinmetz et al., An immunofluorescence test for phospholipase-A2-receptor antibodies and its clinical usefulness in patients with membranous glomerulonephritis, Nephrology Dialysis Transplantation, vol.26, issue.8, pp.2526-2532, 2011.
DOI : 10.1093/ndt/gfr247

H. Debiec and P. Ronco, R Glomerular Deposits in Membranous Nephropathy, New England Journal of Medicine, vol.364, issue.7, pp.689-690, 2011.
DOI : 10.1056/NEJMc1011678

D. Kanigicherla, P. Brenchley, M. Venning, K. Poulton, E. Mckenzie et al., Association of anti-PLA2R with disease activity and outcome in idiopathic membranous nephropathy [abstract], J Am Soc Nephrol, vol.22, p.33, 2011.

J. Hofstra and J. Wetzels, Anti-PLA?R antibodies in membranous nephropathy: Ready for routine clinical practice?, Neth J Med, vol.70, pp.109-113

M. Prunotto, M. Carnevali, G. Candiano, C. Murtas, M. Bruschi et al., Autoimmunity in Membranous Nephropathy Targets Aldose Reductase and SOD2, Journal of the American Society of Nephrology, vol.21, issue.3, pp.507-519, 2010.
DOI : 10.1681/ASN.2008121259

M. Bruschi, M. Carnevali, C. Murtas, G. Candiano, A. Petretto et al., Direct characterization of target podocyte antigens and auto-antibodies in human membranous glomerulonephritis: Alfa-enolase and borderline antigens, Journal of Proteomics, vol.74, issue.10, pp.2008-2017, 2011.
DOI : 10.1016/j.jprot.2011.05.021

H. Debiec, V. Guigonis, B. Mougenot, F. Decobert, J. Haymann et al., Antenatal Membranous Glomerulonephritis Due to Anti???Neutral Endopeptidase Antibodies, New England Journal of Medicine, vol.346, issue.26, pp.2053-2060, 2002.
DOI : 10.1056/NEJMoa012895

H. Debiec, F. Lefeu, M. Kemper, P. Niaudet, G. Deschênes et al., Early-Childhood Membranous Nephropathy Due to Cationic Bovine Serum Albumin, New England Journal of Medicine, vol.364, issue.22, pp.2101-2110, 2011.
DOI : 10.1056/NEJMoa1013792

B. Buis, P. Wever, G. Koomen, B. Van-acker, J. Groothoff et al., Clearance Ratios of Amylase Isoenzymes and IgG Subclasses: Do They Reflect Glomerular Charge Selectivity?, Nephron, vol.75, issue.4, pp.444-450, 1997.
DOI : 10.1159/000189583

J. Van-den-brand, J. Hofstra, and J. Wetzels, Low-Molecular-Weight Proteins as Prognostic Markers in Idiopathic Membranous Nephropathy, Clinical Journal of the American Society of Nephrology, vol.6, issue.12, pp.2846-2853, 2011.
DOI : 10.2215/CJN.04020411